BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33650193)

  • 21. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH
    Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRG1 deficiency in endothelial cells alleviates thioacetamide induced liver fibrosis in mice.
    Shao J; Xu Y; Fang M
    Biochem Biophys Res Commun; 2020 Jan; 521(1):212-219. PubMed ID: 31635808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
    BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.
    He Y; Yang C; Wang Y; Sacher JR; Sims MM; Pfeffer LM; Miller DD
    Bioorg Med Chem; 2022 Jan; 53():116533. PubMed ID: 34863065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels.
    Griffin CT; Curtis CD; Davis RB; Muthukumar V; Magnuson T
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2282-7. PubMed ID: 21262838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.
    Kitchen P; Lee KY; Clark D; Lau N; Lertsuwan J; Sawasdichai A; Satayavivad J; Oltean S; Afford S; Gaston K; Jayaraman PS
    Cancer Res; 2020 Feb; 80(4):757-770. PubMed ID: 31843982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brg1 loss attenuates aberrant wnt-signalling and prevents wnt-dependent tumourigenesis in the murine small intestine.
    Holik AZ; Young M; Krzystyniak J; Williams GT; Metzger D; Shorning BY; Clarke AR
    PLoS Genet; 2014 Jul; 10(7):e1004453. PubMed ID: 25010414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brg1 promotes liver fibrosis via activation of hepatic stellate cells.
    Li H; Lan J; Han C; Guo K; Wang G; Hu J; Gong J; Luo X; Cao Z
    Exp Cell Res; 2018 Mar; 364(2):191-197. PubMed ID: 29427621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/β-catenin pathway in mice.
    Li N; Kong M; Zeng S; Hao C; Li M; Li L; Xu Z; Zhu M; Xu Y
    FASEB J; 2019 Jan; 33(1):327-338. PubMed ID: 30001167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
    Tóth M; Wehling L; Thiess L; Rose F; Schmitt J; Weiler SME; Sticht C; De La Torre C; Rausch M; Albrecht T; Grabe N; Duwe L; Andersen JB; Köhler BC; Springfeld C; Mehrabi A; Kulu Y; Schirmacher P; Roessler S; Goeppert B; Breuhahn K
    BMC Cancer; 2021 Oct; 21(1):1079. PubMed ID: 34615513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma.
    Terada M; Horisawa K; Miura S; Takashima Y; Ohkawa Y; Sekiya S; Matsuda-Ito K; Suzuki A
    Sci Rep; 2016 Oct; 6():34691. PubMed ID: 27698452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
    Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
    J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
    Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
    Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma.
    Yang G; Zong H
    Mol Med Rep; 2016 Jun; 13(6):4786-90. PubMed ID: 27082702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.
    Wang W; Zhong W; Yuan J; Yan C; Hu S; Tong Y; Mao Y; Hu T; Zhang B; Song G
    Oncotarget; 2015 Dec; 6(39):42276-89. PubMed ID: 26474277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
    D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
    J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.